Standard BioTools (LAB) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Standard BioTools (LAB) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 47.8% versus a loss of 75.7%. Over five years, LAB leads with a -87.3% price change compared with -94.7% for RPID. Standard BioTools is the larger company by market cap ($266.4 million vs $45.0 million), about 5.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LAB | RPID |
|---|---|---|
| Share price | $0.6787 | $0.8977 |
| Market cap | $266.44M | $45.03M |
| 1-day change | -6.00% | -4.76% |
| YTD return | -46.98% | -69.04% |
| 1-year return | -47.79% | -75.67% |
| 5-year return | -87.29% | -94.66% |
| EPS (TTM) | $-0.13 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.72 | $4.94 |
| 52-week low | $0.63 | $0.86 |
| Distance from 52-week high | -60.54% | -81.83% |
| Average volume | 1.57M | 272.65K |
| Shares outstanding | 392.58M | 45.66M |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Standard BioTools is about 5.9 times larger than Rapid Micro Biosystems by market value ($266.44M vs $45.03M).
- LAB has outperformed RPID by 27.9 percentage points over the past year.
LAB vs RPID FAQ
Which is bigger, Standard BioTools or Rapid Micro Biosystems?
Standard BioTools (LAB) is larger, with a market capitalization of $266.44M compared with $45.03M for Rapid Micro Biosystems (RPID).
Which stock has performed better over the past year, LAB or RPID?
LAB returned -47.79% over the past 12 months, compared with -75.67% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are Standard BioTools and Rapid Micro Biosystems in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.